Join
Live feed
·
PRReleasevia Quantisnow
Creative Medical Technology Holdings Inc. logo

Creative Medical Technology Holdings Receives Notice of Allowance for the Prevention and/or Treatment of Type 1 Diabetes Using Modulated Immune Cells

ByQuantisnow·Wall Street's wire, on your screen.
CELZ· Creative Medical Technology Holdings Inc.
Finance

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CELZ (Creative Medical Technology Holdings Inc.) and more on Quantisnow.